Successful Use of Recombinant Activated Factor VII (Novoseven®) in Controlling Severe Intra-Abdominal Bleeding after Liver Needle Biopsy

R. Hoffman; A. Mahajana; P. Agmon; Y. Barach; B. Brenner

doi:10.1055/s-0037-1613000

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2002; 87(02): 346-347
DOI: 10.1055/s-0037-1613000

Letters to the Editor

Schattauer GmbH

Successful Use of Recombinant Activated Factor VII (Novoseven^®) in Controlling Severe Intra-Abdominal Bleeding after Liver Needle Biopsy

Authors

R. Hoffman

¹Department of Hematology, Rambam Medical Center and Brace Rappaport Faculty of Medicine, Technion, Haifa, Israel
A. Mahajana

²Department of Surgery A, Rambam Medical Center and Brace Rappaport Faculty of Medicine, Technion, Haifa, Israel
P. Agmon

³Department of Internal Medicine A, Rambam Medical Center and Brace Rappaport Faculty of Medicine, Technion, Haifa, Israel
Y. Barach

⁴Department of Hepatology, Rambam Medical Center and Brace Rappaport Faculty of Medicine, Technion, Haifa, Israel
B. Brenner

¹Department of Hematology, Rambam Medical Center and Brace Rappaport Faculty of Medicine, Technion, Haifa, Israel

Abstract

Full Text

References

References
1 Schulman S. Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: safety, monitoring and cost effectiveness. Semin Thromb Hemost 2000; 26: 421-4.
2 Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high dose factor VIIa in independent of tissue factor. Br J Hematol 1997; 99: 542-7.
3 Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Hemophilia 1999; 05: 253-9.
4 Kenet G, Walden R, Eldad A, Matinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. The Lancet 1999; 354: 1879.
5 Vlot AJ, Ton E, Mackaay AJ, Kramer MH, Gaillard CA. Treataent of a severely bleeding patient without pre-existing coagulopathy with activated recombinant factor VII. Am J Med 2000; 108: 421-2.
6 Hedner U. Recombinant factor VIIa (NOVOSEVEN®) as a hemostatic agent. In: 6th Novo Nordisk symposium on the treatment of bleeding and toombotic disorders. Copenhagen; Denmark: 2001
7 Bernstein DE, Jeffers L, Erhordtsen E, Reddy KR, Glazer S, Squiban P, Bech R, Hedner U, Schiff ER. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 1997; 113: 1930-7.
8 Hendriks HG, Meijer K, de Wolf JT, Klompmaker IJ, Porte RJ, de Kam PJ, Hagenaars AJ, Melsen T, Slooff MJ, Van der Meer J. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: apilot study. Transplantation 2001; 71: 402-5.
9 Martinowitz U, Holcomb JB, Pusateri AE, Stein M, Onaca N, Freidman M, Macaitis JM, Castel D, Hedner U, Hess JR. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 2001; 50: 721-9.